NCT01912118 - The Medasense Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

September 30, 2014

Conditions

Pain

Interventions

DRUG

Propofol

Propofol will be titrated via a target controlled infusion to reach a specific target BIS (as specified in treatment arm)

DRUG

Remifentanil

Remifentanil will be provided by a target controlled infusion to a specific effect site concentration (as specified in treatment arm)

Trial Locations (1)

Leiden University Medical Center, Leiden